Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 169 articles: HTML format Text format

Single Articles

September 2019
1. JI C, Wang W, Lu Q, Fu Y, et al
   A new technique in fresh prostate cancer tissue biobanking based on MRI-transrectal ultrasound fusion biopsy.
   Urology. 2019 Sep 2. pii: S0090-4295(19)30751.
   PubMed     Text format     Abstract available
   
   
   August 2019
2. ARABI A, Deebaja M, Yaguchi G, Pantelic M, et al
   Systematic biopsy does not contribute to disease upgrading in patients undergoing targeted biopsy for PI-RADS 5 lesions identified on magnetic resonance imaging in the course of active surveillance for prostate cancer.
   Urology. 2019 Aug 31. pii: S0090-4295(19)30789.
   PubMed     Text format     Abstract available
   
   
   
3. PENG LC, Mian OY, Lakshminarayanan P, Huang P, et al
   Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
   Urology. 2019 Aug 24. pii: S0090-4295(19)30732.
   PubMed     Text format     Abstract available
   
   
   
4. JOHNSTON MJ, Emara A, Noureldin M, Bott S, et al
   Focal high-intensity focussed ultrasound partial gland ablation for the treatment of localised prostate cancer: a report of medium-term outcomes from a single-centre in the United Kingdom.
   Urology. 2019 Aug 23. pii: S0090-4295(19)30730.
   PubMed     Text format     Abstract available
   
   
   
5. GHABILI K, Swallow M, Sherrer RL, Syed JS, et al
   Association between Tumor Multifocality on Multi-parametric MRI and Detection of Clinically-Significant Prostate Cancer in Lesions with Prostate Imaging Reporting and Data System (PI-RADS) Score 4.
   Urology. 2019 Aug 13. pii: S0090-4295(19)30716.
   PubMed     Text format     Abstract available
   
   
   July 2019
6. PENA A, Qian Z, Lambrechts S, Cabri JN, et al
   Evaluation of implementation outcomes after initiation of a shared decision-making program for men with prostate cancer.
   Urology. 2019 Jul 9. pii: S0090-4295(19)30608.
   PubMed     Text format     Abstract available
   
   
   June 2019
7. MORENO JG, Gomella LG
   Evolution of the Liquid Biopsy in Metastatic Prostate Cancer.
   Urology. 2019 Jun 14. pii: S0090-4295(19)30535.
   PubMed     Text format     Abstract available
   
   
   
8. MARTIN SE, Begun EM, Samir E, Azaiza MT, et al
   Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer.
   Urology. 2019 Jun 12. pii: S0090-4295(19)30513.
   PubMed     Text format     Abstract available
   
   
   
9. HOFFMANN MA, Wieler HJ, Baues C, Kuntz NJ, et al
   Letter-to-the-Editor Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer": "68Ga Scatter Correction to Eliminate Halo-Artifacts in PET Imaging".
   Urology. 2019 Jun 11. pii: S0090-4295(19)30517.
   PubMed     Text format    
   
   
   
10. JACOBS BL, Lopa SH, Yabes JG, Nelson JB, et al
    Change in functional status after prostate cancer treatment among Medicare Advantage beneficiaries.
    Urology. 2019 Jun 7. pii: S0090-4295(19)30508.
    PubMed     Text format     Abstract available
    
    
    
11. LAN T, Chen Y, Su Q, Ye J, et al
    Oncological outcome of cytoreductive radical prostatectomy in prostate cancer patients with bone oligometastases.
    Urology. 2019 Jun 7. pii: S0090-4295(19)30507.
    PubMed     Text format     Abstract available
    
    
    May 2019
12. PICKERSGILL NA, Vetter JM, Raval NS, Andriole GL, et al
    The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
    Urology. 2019;127:68-73.
    PubMed     Text format     Abstract available
    
    
    
13. BEKSAC AT, Sobotka S, Xu P, Gupta A, et al
    Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core Biopsy.
    Urology. 2019;127:80-85.
    PubMed     Text format     Abstract available
    
    
    April 2019
14. DRAULANS C, Everaerts W, Isebaert S, Gevaert T, et al
    Impact of MRI on prostate cancer staging and EAU risk classification.
    Urology. 2019 Apr 30. pii: S0090-4295(19)30386.
    PubMed     Text format     Abstract available
    
    
    
15. MAY A, Henke J, Au D, Raza SJ, et al
    National trends in the utilization of androgen deprivation therapy for very low risk prostate cancer.
    Urology. 2019 Apr 29. pii: S0090-4295(19)30366.
    PubMed     Text format     Abstract available
    
    
    
16. MODI PK, Herrel LA, Kaufman SR, Yan P, et al
    Urologist practice structure and spending for prostate cancer care.
    Urology. 2019 Apr 25. pii: S0090-4295(19)30372.
    PubMed     Text format     Abstract available
    
    
    
17. HOFFMANN MA, Wieler HJ, Baues C, Kuntz NJ, et al
    The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.
    Urology. 2019 Apr 12. pii: S0090-4295(19)30342.
    PubMed     Text format     Abstract available
    
    
    
18. SHELTON JB, Buffington P, Augspurger R, Gaylis F, et al
    Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
    Urology. 2019 Apr 4. pii: S0090-4295(19)30326.
    PubMed     Text format     Abstract available
    
    
    
19. SINGHAL U, Morgan TM, Tosoian JJ
    EDITORIAL COMMENT.
    Urology. 2019;126:82.
    PubMed     Text format    
    
    
    
20. GEJERMAN G
    Editorial Comment.
    Urology. 2019;126:151.
    PubMed     Text format    
    
    
    
21. STEINBERG RL, Johnson BA, Cadeddu JA
    Magnetic-assisted Robotic Surgery to Facilitate Reduced-port Radical Prostatectomy.
    Urology. 2019;126:237.
    PubMed     Text format     Abstract available
    
    
    March 2019
22. FAM MM, Yabes JG, Macleod LC, Bandari J, et al
    Increasing Utilization of Multi-Parametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.
    Urology. 2019 Mar 30. pii: S0090-4295(19)30321.
    PubMed     Text format     Abstract available
    
    
    
23. BRYK DJ, Angermeier KW, Klein EA
    A Case of Metastatic Prostate Cancer to the Urethra that Resolved after Androgen Deprivation Therapy.
    Urology. 2019 Mar 29. pii: S0090-4295(19)30323.
    PubMed     Text format     Abstract available
    
    
    
24. ROCCO B, Sighinolfi MC, Sandri M, Eissa A, et al
    Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation based on a Large and a Single Center Cohort of Prostate Cancer Patients.
    Urology. 2019 Mar 27. pii: S0090-4295(19)30316.
    PubMed     Text format     Abstract available
    
    
    
25. BORETA L, Gadzinski AJ, Wu SY, Xu M, et al
    Location of recurrence by Gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy.
    Urology. 2019 Mar 27. pii: S0090-4295(19)30262.
    PubMed     Text format     Abstract available
    
    
    
26. FREITAS D, Andriole GL, Freedland SJ, Neto BS, et al
    Baseline basal cell hyperplasia is not associated with baseline lower urinary tract symptoms, baseline clinical prostatitis or prostate cancer in repeat biopsies.
    Urology. 2019 Mar 23. pii: S0090-4295(19)30312.
    PubMed     Text format     Abstract available
    
    
    
27. HEIDENREICH A
    Editorial Comment.
    Urology. 2019;125:160-161.
    PubMed     Text format    
    
    
    
28. ARNOLD MJ
    Concerns With "New Evidence for the Benefits of Prostate-specific Antigen Screening: Data from 400,887 Kaiser Permanente Patients".
    Urology. 2019;125:261.
    PubMed     Text format    
    
    
    
29. ALPERT PF
    Reply by Author: "New Evidence for the Benefits of Prostate-Specific Antigen Screening".
    Urology. 2019;125:261-262.
    PubMed     Text format    
    
    
    February 2019
30. ASAFU-ADJEI D, Mikkilineni N, Sebesta E, Hyams E, et al
    Misinformation on the Internet regarding Ablative Therapies for Prostate Cancer.
    Urology. 2019 Feb 25. pii: S0090-4295(19)30205.
    PubMed     Text format     Abstract available
    
    
    
31. EINSTEIN DJ, Patil D, Chipman J, Regan MM, et al
    Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life after Treatment for Localized Prostate Cancer.
    Urology. 2019 Feb 18. pii: S0090-4295(19)30152.
    PubMed     Text format     Abstract available
    
    
    
32. TANIGUCHI H, Kawakita S, Kinoshita H, Murota T, et al
    Testosterone Profiles after Brachytherapy for Localized Prostate Cancer.
    Urology. 2019 Feb 1. pii: S0090-4295(19)30089.
    PubMed     Text format     Abstract available
    
    
    
33. MODI PK
    EDITORIAL COMMENT.
    Urology. 2019;124:105-106.
    PubMed     Text format    
    
    
    January 2019
34. PIKE LRG, Wu J, Chen MH, Loffredo M, et al
    Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30066.
    PubMed     Text format     Abstract available
    
    
    
35. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    PubMed     Text format     Abstract available
    
    
    
36. ZHOU SR, Simopoulos DN, Jayadevan R, Felker ER, et al
    USE OF MRI-GUIDED BIOPSY FOR SELECTION AND FOLLOW-UP OF MEN UNDERGOING HEMI-GLAND CRYOABLATION OF PROSTATE CANCER.
    Urology. 2019 Jan 16. pii: S0090-4295(19)30058.
    PubMed     Text format     Abstract available
    
    
    
37. EGGENER S, Karsh LI, Richardson T, Shindel AW, et al
    A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
    Urology. 2019 Jan 3. pii: S0090-4295(19)30001.
    PubMed     Text format     Abstract available
    
    
    
38. PURYSKO AS
    Editorial comment.
    Urology. 2019;123:196-197.
    PubMed     Text format    
    
    
    
39. RAMIREZ-BACKHAUS M, Bertolo R, Mamber A, Ferrer AG, et al
    Live Surgery for Laparoscopic Radical Prostatectomy-Does it Worsen the Outcomes? A Single-center Experience.
    Urology. 2019;123:133-139.
    PubMed     Text format     Abstract available
    
    
    
40. LI R, Zhang M, Duplisea JJ, Troncoso P, et al
    Detection and Treatment of Primary Prostatic Melanoma.
    Urology. 2019;123:16-19.
    PubMed     Text format     Abstract available
    
    
    
41. KAYE DR, Ye Z, Li J, Herrel LA, et al
    The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
    Urology. 2019;123:114-119.
    PubMed     Text format     Abstract available
    
    
    December 2018
42. HEIDENREICH A
    WITHDRAWN: Impact of Staging 68Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer by Thomas Hope et al.
    Urology. 2018 Dec 21. pii: S0090-4295(18)31326.
    PubMed     Text format    
    
    
    
43. CHANG EM, Punglia RS, Steinberg ML, Raldow AC, et al
    Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer.
    Urology. 2018 Dec 20. pii: S0090-4295(18)31334.
    PubMed     Text format     Abstract available
    
    
    
44. BHAT NR, Vetter JM, Andriole GL, Shetty AS, et al
    MRI-Defined PSA Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy.
    Urology. 2018 Dec 20. pii: S0090-4295(18)31324.
    PubMed     Text format     Abstract available
    
    
    
45. WU SY, Boreta L, Shinohara K, Nguyen H, et al
    Impact of staging (68)Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer.
    Urology. 2018 Dec 20. pii: S0090-4295(18)31321.
    PubMed     Text format     Abstract available
    
    
    
46. MARTIN DT, Ghabili K, Levi A, Humphrey PA, et al
    Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group than PI-RADS Score in Multi-Parametric Prostate MRI-Ultrasound Fusion Targeted Biopsies.
    Urology. 2018 Dec 12. pii: S0090-4295(18)31306.
    PubMed     Text format     Abstract available
    
    
    November 2018
47. CHEN J, Wang ZJ, Zhang KL, Xu YJ, et al
    Selective castration-resistant prostate cancer photothermal ablation with CuS nanoplates.
    Urology. 2018 Nov 21. pii: S0090-4295(18)31215.
    PubMed     Text format     Abstract available
    
    
    
48. CHEN Q, Sun T, Wang F, Gong B, et al
    Long noncoding RNA IGF2AS is acting as an epigenetic tumor suppressor in human prostate cancer.
    Urology. 2018 Nov 10. pii: S0090-4295(18)31137.
    PubMed     Text format     Abstract available
    
    
    October 2018
49. QUARRIER SO, Matloubieh JE, Wu G
    Robot-Assisted Placement of Pelvic Tissue Expander for Radiation after Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence.
    Urology. 2018 Oct 29. pii: S0090-4295(18)31068.
    PubMed     Text format     Abstract available
    
    
    
50. ALBALA D, Manak MS, Varsanik JS, Rashid HH, et al
    Clinical proof-of-concept of a novel platform utilizing biopsy-derived live single cells, phenotypic biomarkers, and machine learning toward a precision risk stratification test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3+3 and 3+4).
    Urology. 2018 Oct 9. pii: S0090-4295(18)31073.
    PubMed     Text format     Abstract available
    
    
    September 2018
51. GIANNARINI G, Girometti R, Crestani A, Rossanese M, et al
    A prospective accuracy study of Prostate Imaging Reporting and Data System version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with whole-mount pathology.
    Urology. 2018 Sep 28. pii: S0090-4295(18)31054.
    PubMed     Text format     Abstract available
    
    
    
52. TEELING F, Raison MN, Shabbir MM, Yap MT, et al
    Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis.
    Urology. 2018 Sep 20. pii: S0090-4295(18)30993.
    PubMed     Text format     Abstract available
    
    
    
53. OBMANN VC, Pahwa S, Tabayayong W, Jiang Y, et al
    Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer.
    Urology. 2018 Sep 7. pii: S0090-4295(18)30920.
    PubMed     Text format     Abstract available
    
    
    
54. MONDA SM, Vetter JM, Andriole GL, Fowler KJ, et al
    Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion.
    Urology. 2018;119:115-120.
    PubMed     Text format     Abstract available
    
    
    
55. AGARWAL DK, Miest TS, Granberg CF, Frank I, et al
    Pediatric Robotic Prostatectomy and Pelvic Lymphadenectomy for Embryonal Rhabdomyosarcoma.
    Urology. 2018;119:143-145.
    PubMed     Text format     Abstract available
    
    
    August 2018
56. DIX DB, McDonald AM, Gordetsky JB, Nix JW, et al
    How Would MRI-Targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?
    Urology. 2018 Aug 30. pii: S0090-4295(18)30911.
    PubMed     Text format     Abstract available
    
    
    
57. SU R, Xu G, Xiang L, Ding S, et al
    A novel scoring system for prediction of prostate cancer based on shear wave elastography and clinical parameters.
    Urology. 2018 Aug 29. pii: S0090-4295(18)30910.
    PubMed     Text format     Abstract available
    
    
    
58. HUNTLEY JH, Coley RY, Carter HB, Radhakrishnan A, et al
    Clinical evaluation of an individualized risk prediction tool for men on active surveillance for prostate cancer.
    Urology. 2018 Aug 29. pii: S0090-4295(18)30903.
    PubMed     Text format     Abstract available
    
    
    
59. CAPOGROSSO P, Capitanio U, Vertosick EA, Ventimiglia E, et al
    Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia.
    Urology. 2018 Aug 20. pii: S0090-4295(18)30783.
    PubMed     Text format     Abstract available
    
    
    
60. LEAPMAN MS, Wang R, Park HS, Yu JB, et al
    Association Between Prostate MRI and Observation for Low-Risk Prostate Cancer.
    Urology. 2018 Aug 11. pii: S0090-4295(18)30815.
    PubMed     Text format     Abstract available
    
    
    
61. HUEN KH, Bergman J
    Editorial Comment.
    Urology. 2018;118:133.
    PubMed     Text format    
    
    
    
62. ALPERT PF
    New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients.
    Urology. 2018;118:119-126.
    PubMed     Text format     Abstract available
    
    
    
63. KAOUK JH, Garisto J, Sagalovich D, Dagenais J, et al
    Robotic Single-port Partial Prostatectomy for Anterior Tumors: Transvesical Approach.
    Urology. 2018;118:242.
    PubMed     Text format     Abstract available
    
    
    July 2018
64. ZWAANS BMM, Bartolone SN, Chancellor MB, Nicolai H, et al
    Altered angiogenic growth factors in urine of prostate cancer survivors with radiation history and radiation cystitis.
    Urology. 2018 Jul 27. pii: S0090-4295(18)30779.
    PubMed     Text format     Abstract available
    
    
    
65. MAHRAN A, Turk A, Buzzy C, Wang M, et al
    Younger Men with Prostate Cancer have Lower Risk of Upgrading while on Active Surveillance: A Meta-analysis and Systematic Review of the Literature.
    Urology. 2018 Jul 26. pii: S0090-4295(18)30773.
    PubMed     Text format     Abstract available
    
    
    
66. KIM AH, Konety B, Chen Z, Schumacher F, et al
    COMPARATIVE EFFECTIVENESS OF LOCAL AND SYSTEMIC THERAPY FOR T4 PROSTATE CANCER.
    Urology. 2018 Jul 7. pii: S0090-4295(18)30630.
    PubMed     Text format     Abstract available
    
    
    
67. MODI PK, Kaufman SR, Qi J, Lane BR, et al
    National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.
    Urology. 2018 Jul 7. pii: S0090-4295(18)30628.
    PubMed     Text format     Abstract available
    
    
    
68. LIU W, Patil D, Howard DH, Moore RH, et al
    Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
    Urology. 2018;117:57-63.
    PubMed     Text format     Abstract available
    
    
    
69. LEUNG AK, Hugar L, Patil D, Wong L, et al
    The Clinical Course of Patients With Prostate-Specific Antigen >/=100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening.
    Urology. 2018;117:101-107.
    PubMed     Text format     Abstract available
    
    
    June 2018
70. HAAHR MK, Jensen CH, Toyserkani NM, Andersen DC, et al
    A 12-Month Follow-up After a Single Intracavernous Injection of Autologous Adipose-derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-label Phase I Clinical Trial.
    Urology. 2018 Jun 27. pii: S0090-4295(18)30586.
    PubMed     Text format     Abstract available
    
    
    
71. MENG Y, Vetter JM, Parker AA, Arett CT, et al
    Improved Detection of Clinically Significant Prostate Cancer with Software-Assisted Systematic Biopsy Using MR/US Fusion in Patients with Negative Prostate MRI.
    Urology. 2018 Jun 26. pii: S0090-4295(18)30588.
    PubMed     Text format     Abstract available
    
    
    
72. RASKOLNIKOV D, Gore JL
    Editorial Comment.
    Urology. 2018;116:74-75.
    PubMed     Text format    
    
    
    
73. CURCI NE, Lane BR, Shankar PR, Noyes SL, et al
    Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
    Urology. 2018;116:137-143.
    PubMed     Text format     Abstract available
    
    
    
74. SHAH N, Ioffe V
    Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65).
    Urology. 2018;116:232.
    PubMed     Text format    
    
    
    
75. WELK B, Winick-Ng J, McClure JA, Lorenzo AJ, et al
    The Impact of the Choosing Wisely Campaign in Urology.
    Urology. 2018;116:81-86.
    PubMed     Text format     Abstract available
    
    
    May 2018
76. MEDINA LG, Cacciamani GE, Hernandez A, Landsberger H, et al
    Robotic Management of Recto-Urethral Fistulas after Focal Treatment for Prostate Cancer.
    Urology. 2018 May 22. pii: S0090-4295(18)30469.
    PubMed     Text format     Abstract available
    
    
    
77. KAYE DR, Qi J, Morgan TM, Linsell S, et al
    Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30471.
    PubMed     Text format     Abstract available
    
    
    
78. BUELENS S, Van Praet C, Poelaert F, Van Huele A, et al
    Prospective, Randomized Controlled Trial Exploring the Effect of TachoSil(R) on Lymphocele Formation after Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Urology. 2018 May 15. pii: S0090-4295(18)30463.
    PubMed     Text format     Abstract available
    
    
    
79. ZHANG S, Li LH, Qiao HM, Yang X, et al
    Regulation of the Antioxidant-Response by MyoD Transcriptional Coactivator in Castration-Resistant Prostate Cancer Cells.
    Urology. 2018 May 3. pii: S0090-4295(18)30397.
    PubMed     Text format     Abstract available
    
    
    
80. LI Q, Xiang F, Lin X, Grajo JR, et al
    The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along Ten Imaging Touch Points.
    Urology. 2018 May 3. pii: S0090-4295(18)30395.
    PubMed     Text format     Abstract available
    
    
    
81. MERRET C, Mannas M, Black PC, Zargar H, et al
    Magnet before the Needle: Commentary on MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (PRECISION Trial).
    Urology. 2018 May 3. pii: S0090-4295(18)30393.
    PubMed     Text format    
    
    
    
82. PORPIGLIA F, Fiori C, Checcucci E, Amparore D, et al
    Augmented Reality Robot-assisted Radical Prostatectomy: Preliminary Experience.
    Urology. 2018;115:184.
    PubMed     Text format     Abstract available
    
    
    
83. HENRY MA, Howard DH, Davies BJ, Filson CP, et al
    Physician Reimbursement for Prostate Biopsies Falls as Procedures Shift From Offices to Facilities.
    Urology. 2018;115:96-101.
    PubMed     Text format     Abstract available
    
    
    
84. HEIDLER S, Drerup M, Lusuardi L, Bannert U, et al
    The Correlation of Prostate Volume and Prostate-specific Antigen Levels With Positive Bacterial Prostate Tissue Cultures.
    Urology. 2018;115:151-156.
    PubMed     Text format     Abstract available
    
    
    
85. FULLER TW, Ristau BT, Tepe SM, Benoit RM, et al
    Characterizing Clinically Meaningful Changes in Lower Urinary Tract Symptoms Using the American Urological Association Symptom Index.
    Urology. 2018;115:139-143.
    PubMed     Text format     Abstract available
    
    
    
86. MEYER AR, Joice GA, Schwen ZR, Partin AW, et al
    Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.
    Urology. 2018;115:8-13.
    PubMed     Text format     Abstract available
    
    
    
87. KARSH LI, Gross ET, Pieczonka CM, Aliotta PJ, et al
    Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Urology. 2018;115:39-44.
    PubMed     Text format     Abstract available
    
    
    
88. BRASSETTI A, D'Elia G
    Reply by the Authors.
    Urology. 2018;115:189.
    PubMed     Text format    
    
    
    April 2018
89. LUCKENBAUGH AN, Hollenbeck BK, Kaufman SR, Yan P, et al
    Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30300.
    PubMed     Text format     Abstract available
    
    
    
90. VELASQUEZ MC, Chinea FM, Kwon D, Prakash NS, et al
    The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality after Radical Prostatectomy in Hispanic/Latino Men: A Population-Based Analysis.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30293.
    PubMed     Text format     Abstract available
    
    
    
91. DE RIESE W, Verlage K, Grand R, de Riese CS, et al
    Re: Turini et al.: The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement (Urology 2017;104:122-130).
    Urology. 2018;114:246.
    PubMed     Text format    
    
    
    
92. NEAD KT, Boldbaatar N, Yang DD, Sinha S, et al
    Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis.
    Urology. 2018;114:155-162.
    PubMed     Text format     Abstract available
    
    
    
93. FRIEDL A, Schneeweiss J, Sevcenco S, Eredics K, et al
    In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve.
    Urology. 2018;114:139-146.
    PubMed     Text format     Abstract available
    
    
    
94. SRIVASTAVA A, Joice GA, Patel HD, Manka MG, et al
    Impact of Adjuvant Radiation on Artificial Urinary Sphincter Durability in Postprostatectomy Patients.
    Urology. 2018;114:212-217.
    PubMed     Text format     Abstract available
    
    
    
95. SHAPIRO DD, Goodspeed DC, Bushman W
    Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures.
    Urology. 2018;114:207-211.
    PubMed     Text format     Abstract available
    
    
    March 2018
96. KESCH C, Black PC
    Filling a True Unmet Need: a New Therapy for Non-Metastatic Castrate Resistant Prostate Cancer. Commentary on: Apalutamide Treatment and Metastasis-Free Survival in Prostate Cancer.
    Urology. 2018 Mar 26. pii: S0090-4295(18)30260.
    PubMed     Text format    
    
    
    
97. BJURLIN MA, Turkbey B, Rosenkrantz AB, Gaur S, et al
    Imaging the High-Risk Prostate Cancer Patient: Current and Future Approaches to Staging.
    Urology. 2018 Mar 12. pii: S0090-4295(17)31305.
    PubMed     Text format     Abstract available
    
    
    
98. DELAY KJ, Haney NM, Chiang J, Stewart C, et al
    Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective Analysis.
    Urology. 2018;113:160-165.
    PubMed     Text format     Abstract available
    
    
    
99. WEAVER JK, Kim EH, Vetter JM, Shetty A, et al
    Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
    Urology. 2018;113:119-128.
    PubMed     Text format     Abstract available
    
    
    
100. CARPENTER CP, Gleason JM
     When Chemotherapy Is Not Enough-Management of Prostatic Embryonal Rhabdomyosarcoma in an Infant.
     Urology. 2018;113:200-202.
     PubMed     Text format     Abstract available
     
     
     
101. RADADIA KD, Farber NJ, Shinder B, Polotti CF, et al
     Management of Postradical Prostatectomy Urinary Incontinence: A Review.
     Urology. 2018;113:13-19.
     PubMed     Text format     Abstract available
     
     
     
102. KO KJ, Lee CU, Kim TH, Suh YS, et al
     Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
     Urology. 2018;113:215-219.
     PubMed     Text format     Abstract available
     
     
     February 2018
103. RADHAKRISHNAN A, Grande D, Mitra N, Pollack CE, et al
     Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
     Urology. 2018 Feb 22. pii: S0090-4295(18)30160.
     PubMed     Text format     Abstract available
     
     
     
104. WOJNO L, Minutella C, Moylan D, Bush A, et al
     Specimen Provenance Testing Identifies Contamination That Affects Molecular Prognostic Assay Results in Prostate Cancer Biopsy Specimens.
     Urology. 2018 Feb 21. pii: S0090-4295(18)30162.
     PubMed     Text format     Abstract available
     
     
     
105. SATAKE Y, Kaiho Y, Saito H, Yamada T, et al
     Estimated Minimal Residual Membranous Urethral Length on Preoperative Magnetic Resonance Imaging Can Be a New Predictor for Continence After Radical Prostatectomy.
     Urology. 2018;112:138-144.
     PubMed     Text format     Abstract available
     
     
     
106. KAYE DR, Syrjamaki J, Ellimoottil C, Schervish EW, et al
     Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy.
     Urology. 2018;112:74-79.
     PubMed     Text format     Abstract available
     
     
     
107. VETTERLEIN MW, Dalela D, Sammon JD, Karabon P, et al
     State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
     Urology. 2018;112:56-65.
     PubMed     Text format     Abstract available
     
     
     
108. ELKHOURY FF, Simopoulos DN, Marks LS
     Targeted Prostate Biopsy in the Era of Active Surveillance.
     Urology. 2018;112:12-19.
     PubMed     Text format     Abstract available
     
     
     January 2018
109. CANCIAN M, Renzulli JF 2nd
     Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
     Urology. 2018 Jan 18. pii: S0090-4295(18)30044.
     PubMed     Text format     Abstract available
     
     
     
110. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
     Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
     Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
     PubMed     Text format     Abstract available
     
     
     
111. BRASSETTI A, Lombardo R, Emiliozzi P, Cardi A, et al
     Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket.
     Urology. 2018;111:129-135.
     PubMed     Text format     Abstract available
     
     
     
112. CHRISTIDIS D, McGrath S, Leaney B, O'Sullivan R, et al
     Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
     Urology. 2018;111:136-138.
     PubMed     Text format     Abstract available
     
     
     December 2017
113. TANG V, Campbell P, Pattison DA
     Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
     Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
     PubMed     Text format     Abstract available
     
     
     
114. WERNEBURG GT, Kongnyuy M, Halpern DM, Salcedo JM, et al
     Effects of Focal Versus Total Cryotherapy and Minimum Tumor Temperature on Patient-Reported Quality of Life as Compared to Active Surveillance in Prostate Cancer Patients.
     Urology. 2017 Dec 22. pii: S0090-4295(17)31302.
     PubMed     Text format     Abstract available
     
     
     
115. KAHOKEHR AA, Peterson AC
     Unmasking of Urinary-Pubic Symphysis Fistula (UPF) after Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors - User Beware. Url-D-17-02187.
     Urology. 2017 Dec 22. pii: S0090-4295(17)31301.
     PubMed     Text format     Abstract available
     
     
     
116. ULLMAN D, Dorn D, Rais-Bahrami S, Gordetsky J, et al
     Clinical Utility and Biologic implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
     Urology. 2017 Dec 7. pii: S0090-4295(17)31219.
     PubMed     Text format     Abstract available
     
     
     November 2017
117. WALLIS CJD, Satkunasivam R, Saskin R, Bansal S, et al
     Population-Based Analysis of Treatment Toxicity among Men with Castration-Resistant Prostate Cancer: a Phase IV Study.
     Urology. 2017 Nov 27. pii: S0090-4295(17)31221.
     PubMed     Text format     Abstract available
     
     
     
118. CHUNG PH, Esposito P, Wessells H, Voelzke BB, et al
     Incidence of Stress Urinary Incontinence Following Posterior Urethroplasty for Radiation-Induced Urethral Strictures.
     Urology. 2017 Nov 27. pii: S0090-4295(17)31222.
     PubMed     Text format     Abstract available
     
     
     
119. 
     Erratum to "Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival".
     Urology. 2017 Nov 20. pii: S0090-4295(17)31088.
     PubMed     Text format    
     
     
     
120. BJURLIN MA, Rosenkrantz AB, Sarkar S, Lepor H, et al
     Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
     Urology. 2017 Nov 16. pii: S0090-4295(17)31185.
     PubMed     Text format     Abstract available
     
     
     
121. BARQAWI A, Huebner E, Krughoff K, O'Donnell CI, et al
     Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-Confined Prostate Cancer.
     Urology. 2017 Nov 7. pii: S0090-4295(17)31163.
     PubMed     Text format     Abstract available
     
     
     October 2017
122. ZHONG W, Smith B, Haghighi K, Mancuso P, et al
     Systematic Review of Decision Aids for the Management of Men with Localized Prostate Cancer.
     Urology. 2017 Oct 31. pii: S0090-4295(17)31154.
     PubMed     Text format     Abstract available
     
     
     
123. SHARMA V, Yousefi K, Haddad Z, Buerki C, et al
     Gene Expression Correlates of Site-Specific Metastasis among Men with Lymph Node Positive Prostate Cancer Treated with Radical Prostatectomy: a Case Series.
     Urology. 2017 Oct 24. pii: S0090-4295(17)31099.
     PubMed     Text format     Abstract available
     
     
     
124. KENIGSBERG AP, Llukani E, Deng FM, Melamed J, et al
     The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
     Urology. 2017 Oct 20. pii: S0090-4295(17)31097.
     PubMed     Text format     Abstract available
     
     
     
125. NGUYEN A, O'Leary MP
     Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017, http://dx.doi.org/doi:10.1016/j.urology.2017.08.032).
     Urology. 2017 Oct 16. pii: S0090-4295(17)31076.
     PubMed     Text format    
     
     
     September 2017
126. QURESHI ZP, Sartor O, Bennett CL
     Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer.
     Urology. 2017 Sep 20. pii: S0090-4295(17)30750.
     PubMed     Text format    
     
     
     
127. SHORE N, Heidenreich A, Saad F
     Author Response on the Manuscript Titled "Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer" (#URL-D-17-01121).
     Urology. 2017 Sep 20. pii: S0090-4295(17)30751.
     PubMed     Text format    
     
     
     
128. GOLOMBOS DM, Ayangbesan A, O'Malley P, Lewicki P, et al
     The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: a Prospective, Pilot Study.
     Urology. 2017 Sep 6. pii: S0090-4295(17)30957.
     PubMed     Text format     Abstract available
     
     
     
129. WIENER S, Haddock P, Cusano J, Staff I, et al
     Incidence of Clinically Significant Prostate Cancer after a Diagnosis of Atypical Small Acinar Proliferation (ASAP), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), or Benign Tissue.
     Urology. 2017 Sep 6. pii: S0090-4295(17)30958.
     PubMed     Text format     Abstract available
     
     
     
130. DEEBEL NA, Morin JP, Autorino R, Vince R, et al
     Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
     Urology. 2017 Sep 4. pii: S0090-4295(17)30906.
     PubMed     Text format     Abstract available
     
     
     August 2017
131. BOESEN L, Norgaard N, Logager V, Balslev I, et al
     Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
     Urology. 2017 Aug 30. pii: S0090-4295(17)30899.
     PubMed     Text format     Abstract available
     
     
     
132. FRIEDL A, Stangl K, Bauer W, Kivaranovic D, et al
     Prostate-Specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction with the in-Bore 3-T MRI-Guided Transrectal Targeted Prostate Biopsy after Negative 12-Core Biopsy.
     Urology. 2017 Aug 24. pii: S0090-4295(17)30880.
     PubMed     Text format     Abstract available
     
     
     
133. OROM H, Biddle C, Underwood W 3rd, Homish GG, et al
     Racial/Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-Specific Quality of Life.
     Urology. 2017 Aug 22. pii: S0090-4295(17)30866.
     PubMed     Text format     Abstract available
     
     
     
134. BHINDI B, Carlson RE, Mason RJ, Schulte PJ, et al
     Long-Term Follow Up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer with a Positive Surgical Margin.
     Urology. 2017 Aug 17. pii: S0090-4295(17)30853.
     PubMed     Text format     Abstract available
     
     
     
135. AAS K, Axcrona K, Kvale R, Moller B, et al
     10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
     Urology. 2017 Aug 17. pii: S0090-4295(17)30860.
     PubMed     Text format     Abstract available
     
     
     
136. SHORE N, Heidenreich A, Saad F
     Predicting Response and Recognizing Resistance: Improving Outcomes in Patients with Castration-Resistant Prostate Cancer.
     Urology. 2017 Aug 7. pii: S0090-4295(17)30745.
     PubMed     Text format     Abstract available
     
     
     
137. STRUSS WJ, Black PC
     Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-Sensitive Prostate Cancer.
     Urology. 2017 Aug 7. pii: S0090-4295(17)30779.
     PubMed     Text format    
     
     
     July 2017
138. ZACHO HD, Gade M, Mortensen JC, Bertelsen H, et al
     Bone Scan Index is an Independent Predictor for Time to Castration-Resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: a Prospective Study.
     Urology. 2017 Jul 28. pii: S0090-4295(17)30759.
     PubMed     Text format     Abstract available
     
     
     
139. ZACHO HD, Petersen LJ
     Reply by the authors to the Editorial on: Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Petersen LJ. Bone scan index is an independent predictor for time to castration resistant prostate cancer in newly diagnosed prostate cancer: A prospect
     Urology. 2017 Jul 26. pii: S0090-4295(17)30760.
     PubMed     Text format    
     
     
     
140. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
     Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
     Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
     PubMed     Text format     Abstract available
     
     
     June 2017
141. SKOLARUS TA, Ragnoni JA, Garlinghouse C, Schafenacker A, et al
     Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care.
     Urology. 2017 Jun 23. pii: S0090-4295(17)30637.
     PubMed     Text format     Abstract available
     
     
     
142. GORIN MA, Pienta KJ, Pomper MG, Rowe SP, et al
     Prostate Cancer Local Recurrence Detected with Both 18F-Fluciclovine and PSMA-Targeted 18F-DCFPyL PET/CT.
     Urology. 2017 Jun 19. pii: S0090-4295(17)30635.
     PubMed     Text format     Abstract available
     
     
     
143. MANNAS M, Chedgy E, Black PC
     You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer.
     Urology. 2017 Jun 15. pii: S0090-4295(17)30625.
     PubMed     Text format    
     
     
     
144. GRIVAS N, van der Roest R, Tillier C, Schouten D, et al
     Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging are Correlated with Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-Assisted Radical Prostatectomy for Prostate Cancer.
     Urology. 2017 Jun 7. pii: S0090-4295(17)30604.
     PubMed     Text format     Abstract available
     
     
     May 2017
145. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
     Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
     Urology. 2017 May 25. pii: S0090-4295(17)30565.
     PubMed     Text format     Abstract available
     
     
     April 2017
146. DAVIS K, Bellini P, Hagerman C, Zinar R, et al
     Physicians' Perceptions of Factors Influencing the Treatment Decision-Making Process for Men with Low-Risk Prostate Cancer.
     Urology. 2017 Apr 25. pii: S0090-4295(17)30391.
     PubMed     Text format     Abstract available
     
     
     
147. CANTIELLO F, Gangemi V, Cascini GL, Calabria F, et al
     Diagnostic Accuracy of 64Cu-PSMA PET/CT for Primary Lymph Node Staging of Intermediate to High Risk Prostate Cancer: Our Preliminary Experience.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30385.
     PubMed     Text format     Abstract available
     
     
     
148. XIA L, Zeh R, Mizelle J, Newton A, et al
     Near-Infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30386.
     PubMed     Text format     Abstract available
     
     
     
149. MANNING TG, Cheung E, Perera M, Christidis D, et al
     Atypical Small Acinar Proliferation and High Grade Prostatic Intraepithelial Neoplasia in the Era of Multi-Parametric MRI: a Contemporary Review.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30388.
     PubMed     Text format     Abstract available
     
     
     
150. POELAERT F, Verbaeys C, Rappe B, Kimpe B, et al
     Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective LoMP Trial.
     Urology. 2017 Apr 20. pii: S0090-4295(17)30372.
     PubMed     Text format     Abstract available
     
     
     
151. JUE JS, Barboza MP, Prakash NS, Venkatramani V, et al
     Re-Examining PSA Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
     Urology. 2017 Apr 18. pii: S0090-4295(17)30368.
     PubMed     Text format     Abstract available
     
     
     
152. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
     Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
     Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
     PubMed     Text format     Abstract available
     
     
     March 2017
153. JOHNSTON J, Struss WJ, Black PC
     Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
     Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
     PubMed     Text format    
     
     
     
154. STRUSS WJ, Black PC
     Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
     Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
     PubMed     Text format    
     
     
     
155. PAKZAD R, Safiri S
     Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
     Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
     PubMed     Text format    
     
     
     
156. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
     Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
     Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
     PubMed     Text format    
     
     
     
157. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
     Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
     Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
     PubMed     Text format     Abstract available
     
     
     
158. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
     Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
     Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
     PubMed     Text format     Abstract available
     
     
     
159. PAKZAD R, Safiri S
     Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
     Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
     PubMed     Text format    
     
     
     
160. 
     Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
     Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
     PubMed     Text format    
     
     
     February 2017
161. JOHNSON SC, Packiam VT, Golan S, Cohen AJ, et al
     The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive Prostatectomy.
     Urology. 2017;100:111-116.
     PubMed     Text format     Abstract available
     
     
     
162. BORHAN W, Epstein JI
     Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
     Urology. 2017;100:175-179.
     PubMed     Text format     Abstract available
     
     
     
163. KOMINSKY HD, Bashline M, Eun D, Pontari MA, et al
     Use of Age and Medical Comorbidity to Assess Long-term Other-cause Mortality Risk in a Cohort of Men Undergoing Prostate Biopsy at an Academic Medical Center.
     Urology. 2017;100:169-174.
     PubMed     Text format     Abstract available
     
     
     January 2017
164. ZARGAR-SHOSHTARI K, Lawrentschuk N, Zargar H
     Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.
     Urology. 2017;99:3-4.
     PubMed     Text format    
     
     
     August 2016
165. LIU JS, Hofer MD, Sheth KR, Cordon BH, et al
     Improving Outcomes of Bulbomembranous Urethroplasty for Radiation-Induced Urethral Strictures in Post-Urolume Era.
     Urology. 2016 Aug 2. pii: S0090-4295(16)30459.
     PubMed     Text format     Abstract available
     
     
     July 2016
166. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
     Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
     Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
     PubMed     Text format     Abstract available
     
     
     May 2016
167. QUINTANA L, Ward A, Gerrin SJ, Genega EM, et al
     Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
     Urology. 2016;91:143-9.
     PubMed     Text format     Abstract available
     
     
     
168. KARATZAS AD, Zachos I, Mitrakas L, Dimitropoulos K, et al
     Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series.
     Urology. 2016;91:e3-4.
     PubMed     Text format     Abstract available
     
     
     
169. DASON S, Allard CB, Wright I, Shayegan B, et al
     Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique.
     Urology. 2016;91:129-35.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: